Dengue in Cuba: research strategy to support dengue control

The Lancet

Volumn 374, Issue 9702, 2009, Pages 1660-1661

  Guzmán, Maria G ^a   Kourí, Gustavo ^a  

^a INSTITUTO DE MEDICINA TROPICAL PEDRO KOURÍ   (Cuba)

Author keywords

[No Author keywords available]

Indexed keywords

DENGUE VACCINE; INSECTICIDE;

AEDES AEGYPTI; ARTICLE; COST EFFECTIVENESS ANALYSIS; CUBA; DENGUE; EARLY DIAGNOSIS; HUMAN; IMMUNOGENICITY; INFECTION CONTROL; INFECTION RISK; LABORATORY TEST; PRIORITY JOURNAL; SECONDARY INFECTION;

CUBA; DENGUE; DENGUE VACCINES; HEALTH SERVICES NEEDS AND DEMAND; HUMANS; MOSQUITO CONTROL; RESEARCH; WORLD HEALTH;

EID: 70449356794     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(09)61975-9     Document Type: Note

References (15)

1. Guzmán M.G. Deciphering dengue: the Cuban experience. Science 309 (2005) 1495-1497
2. Halstead S.B. Observations related to pathogenesis of dengue hemorrhagic fever VI: hypothesis and discussion. Yale J Biol Med 42 (1970) 350-362
3. Guzmán M.G., Kourí G., Valdés L., Bravo J., Vázquez S., and Halstead S.B. Enhanced severity of secondary dengue 2 infections: deaths rates in 1981 and 1997 Cuban outbreaks. Rev Panam Salud Publica 11 (2002) 223-227
4. Kourí G., Guzmán M.G., Bravo J., and Triana C. Dengue hemorrhagic fever/dengue shock syndrome (DHF/DSS): lessons from the Cuban epidemic, 1981. Bull World Health Organ 67 (1989) 375-380
5. Sierra B., García G., Pérez A.B., et al. Ethnicity and difference in dengue virus-specific memory T cell responses in Cuban individuals. Viral Immunol 19 (2006) 662-668
6. Rodríguez Roche R., Alvarez M., Gritsun T., et al. Virus evolution during a severe dengue epidemic in Cuba, 1997. Virology 334 (2005) 154-159
7. Alvarez M., Rodríguez-Roche R., Bernardo L., et al. Dengue hemorrhagic fever caused by sequential dengue 1-3 infections at a long interval: Havana epidemic, 2001-2002. Am J Trop Med Hyg 75 (2006) 1113-1117
8. Sierra B., Alegre R., Pérez A.B., et al. HLA A, B and DRB1 allele frequencies in Cuban individuals with antecedents of dengue 2 disease: advantages of the Cuban population for HLA studies of dengue virus infection. Hum Immunol 68 (2007) 531-540
9. Pérez A.B., García G., Sierra B., et al. IL-10 levels in Dengue patients: some findings from the exceptional epidemiological conditions in Cuba. J Med Virol 73 (2004) 230-234
10. Vázquez S., Valdivia I., Sánchez A., Calzada N., and Guzmán M.G. Evaluation of the diagnostic UMELISA dengue IgM PLUS kit. Arch Venezolanos Med Trop 5 (2007) 4-19 (in Spanish)
11. Vázquez S., Cabezas S., Pérez A.B., et al. Kinetics of antibodies in sera, saliva and urine samples from adult patients with primary or secondary dengue 3 virus infections. Int J Infect Dis 11 (2007) 256-262
12. Hermida L., Bernardo L., Martín J., et al. A recombinant fusion protein containing the domain III of the dengue 2 envelope protein is immunogenic and protective in nonhuman primates. Vaccine 24 (2006) 3165-3171
13. Bisset J.A., Marquetti M.C., Suarez S., Rodríguez M.M., and Padmanabha H. Application of the pupal/demographic-survey methodology in an area of Havana, Cuba, with low densities of Aedes aegypti. Ann Trop Med Parasitol 100 suppl 1 (2006) 45-51
14. Baly A., Toledo M.E., Vanlerberghe V., et al. Cost-effectiveness of a community-based approach intertwined with a vertical Aedes control program. Am J Trop Med Hyg 81 (2009) 88-93
15. WHO. Report on dengue. 2007. http://apps.who.int/tdr/svc/publications/tdr-research-publications/swg-report-dengue (accessed Nov 1, 2009).